Morgan Stanley’s Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share JEMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-794,364
Closed -$5.11M 8102
2022
Q3
$5.11M Sell
794,364
-27,410
-3% -$179K ﹤0.01% 3670
2022
Q2
$5.5M Sell
821,774
-20,882
-2% -$144K ﹤0.01% 3681
2022
Q1
$5.9M Sell
842,656
-122,439
-13% -$889K ﹤0.01% 3504
2021
Q4
$7.31M Buy
965,095
+32,264
+3% +$251K ﹤0.01% 3312
2021
Q3
$7.45M Buy
932,831
+31,873
+4% +$258K ﹤0.01% 3273
2021
Q2
$7.32M Buy
900,958
+46,246
+5% +$376K ﹤0.01% 3366
2021
Q1
$6.75M Buy
854,712
+134,299
+19% +$1.05M ﹤0.01% 3087
2020
Q4
$5.39M Sell
720,413
-136,061
-16% -$1M ﹤0.01% 3181
2020
Q3
$6.59M Buy
856,474
+19,420
+2% +$145K ﹤0.01% 2441
2020
Q2
$5.99M Buy
837,054
+39,789
+5% +$261K ﹤0.01% 2477
2020
Q1
$4.93M Sell
797,265
-87,567
-10% -$738K ﹤0.01% 2477
2019
Q4
$7.88M Buy
884,832
+97,743
+12% +$861K ﹤0.01% 2681
2019
Q3
$6.85M Buy
787,089
+112,015
+17% +$1M ﹤0.01% 2531
2019
Q2
$6M Buy
675,074
+76,877
+13% +$671K ﹤0.01% 2727
2019
Q1
$5.2M Buy
598,197
+110,628
+23% +$931K ﹤0.01% 2670
2018
Q4
$3.72M Sell
487,569
-48,450
-9% -$375K ﹤0.01% 3221
2018
Q3
$4.38M Buy
536,019
+35,494
+7% +$297K ﹤0.01% 3319
2018
Q2
$4.37M Buy
500,525
+63,728
+15% +$568K ﹤0.01% 3304
2018
Q1
$3.93M Buy
436,797
+46,479
+12% +$433K ﹤0.01% 3301
2017
Q4
$3.67M Buy
390,318
+389,626
+56,304% +$3.85M ﹤0.01% 3433
2017
Q3
$7K Buy
+692
New +$6.93K ﹤0.01% 6244

Morgan Stanley's JEMD Position: Q4 2022 in Review

Morgan Stanley sold out of Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share (JEMD) in Q4 2022, closing a stake of 794,364 shares — an estimated $5.11M sold.

Morgan Stanley first reported a position in JEMD in Q3 2017 and held it in 21 quarters. The position peaked at $7.88M in Q4 2019. 0 funds tracked by Wall St. Rank hold JEMD as of Q4 2022.

  • Morgan Stanley reported no remaining Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share position as of Q4 2022 after selling out during the quarter.
  • Morgan Stanley sold 794,364 Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share shares in Q4 2022, an estimated $5.11M.
  • Morgan Stanley first reported a position in Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share in Q3 2017 and held it in 21 quarters.
  • Morgan Stanley's Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share position peaked at $7.88M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share as of Q4 2022.

Based on Morgan Stanley's 13F filing for Q4 2022, filed 14 Feb 2023.